Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)

Homologous recombination deficiency (HRD) is a predictive marker for response to poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian carcinoma. HRD scores have entered routine diagnostics, but the influence of algorithms, parameters and confounders has not been analyzed comprehensively. A ser...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Menzel, Michael (VerfasserIn) , Endris, Volker (VerfasserIn) , Schwab, Constantin (VerfasserIn) , Kluck, Klaus (VerfasserIn) , Neumann, Olaf (VerfasserIn) , Beck, Susanne (VerfasserIn) , Ball, Markus (VerfasserIn) , Schaaf, Christian P. (VerfasserIn) , Fröhling, Stefan (VerfasserIn) , Lichtner, Peter (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Kazdal, Daniel (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Budczies, Jan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2023
In: Translational oncology
Year: 2023, Jahrgang: 35, Pages: 1-10
ISSN:1936-5233
DOI:10.1016/j.tranon.2023.101706
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.tranon.2023.101706
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S193652332300092X
Volltext
Verfasserangaben:Michael Menzel, Volker Endris, Constantin Schwab, Klaus Kluck, Olaf Neumann, Susanne Beck, Markus Ball, Christian Schaaf, Stefan Fröhling, Peter Lichtner, Peter Schirmacher, Daniel Kazdal, Albrecht Stenzinger, Jan Budczies

MARC

LEADER 00000caa a2200000 c 4500
001 1854258958
003 DE-627
005 20240329080202.0
007 cr uuu---uuuuu
008 230803s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.tranon.2023.101706  |2 doi 
035 |a (DE-627)1854258958 
035 |a (DE-599)KXP1854258958 
035 |a (OCoLC)1425213466 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Menzel, Michael  |e VerfasserIn  |0 (DE-588)1247100944  |0 (DE-627)1780550677  |4 aut 
245 1 0 |a Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)  |c Michael Menzel, Volker Endris, Constantin Schwab, Klaus Kluck, Olaf Neumann, Susanne Beck, Markus Ball, Christian Schaaf, Stefan Fröhling, Peter Lichtner, Peter Schirmacher, Daniel Kazdal, Albrecht Stenzinger, Jan Budczies 
264 1 |c September 2023 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 14. Juni 2023 
500 |a Gesehen am 03.08.2023 
520 |a Homologous recombination deficiency (HRD) is a predictive marker for response to poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian carcinoma. HRD scores have entered routine diagnostics, but the influence of algorithms, parameters and confounders has not been analyzed comprehensively. A series of 100 poorly differentiated ovarian carcinoma samples was analyzed using whole exome sequencing (WES) and genotyping. Tumor purity was determined using conventional pathology, digital pathology, and two bioinformatic methods. HRD scores were calculated from copy number profiles determined by Sequenza and by Sclust either with or without fixed tumor purity. Tumor purity determination by digital pathology combined with a tumory purity informed variant of Sequenza served as reference method for HRD scoring. Seven tumors had deleterious mutations in BRCA1/2, 12 tumors had deleterious mutations in other homologous recombination repair (HRR) genes, 18 tumors had variants of unknown significance (VUS) in BRCA1/2 or other HRR genes, while the remaining 63 tumors had no relevant alterations. Using the reference method for HRD scoring, 68 tumors were HRD-positive. HRDsum determined by WES correlated strongly with HRDsum determined by single nucleotide polymorphism (SNP) arrays (R = 0.85). Conventional pathology systematically overestimated tumor purity by 8% compared to digital pathology. All investigated methods agreed on classifying the deleterious BRCA1/2-mutated tumors as HRD-positive, but discrepancies were observed for some of the remaining tumors. Discordant HRD classification of 11% of the tumors was observed comparing the tumor purity uninformed default of Sequenza and the reference method. In conclusion, tumor purity is a critical factor for the determination of HRD scores. Assistance by digital pathology helps to improve accuracy and imprecision of its estimation. 
650 4 |a Homologous recombination deficiency 
650 4 |a HRD 
650 4 |a Tumor cell content 
650 4 |a Tumor purity 
650 4 |a WES 
650 4 |a Whole exome sequencing 
700 1 |a Endris, Volker  |e VerfasserIn  |0 (DE-588)1063753686  |0 (DE-627)812590961  |0 (DE-576)422898198  |4 aut 
700 1 |a Schwab, Constantin  |d 1992-  |e VerfasserIn  |0 (DE-588)1106892291  |0 (DE-627)863243045  |0 (DE-576)474954269  |4 aut 
700 1 |a Kluck, Klaus  |e VerfasserIn  |0 (DE-588)122679940X  |0 (DE-627)1747876127  |4 aut 
700 1 |a Neumann, Olaf  |e VerfasserIn  |0 (DE-588)1033375632  |0 (DE-627)741119498  |0 (DE-576)380962381  |4 aut 
700 1 |a Beck, Susanne  |d 1985-  |e VerfasserIn  |0 (DE-588)1164102362  |0 (DE-627)1028488866  |0 (DE-576)508378915  |4 aut 
700 1 |a Ball, Markus  |e VerfasserIn  |0 (DE-588)1057908746  |0 (DE-627)795401108  |0 (DE-576)41391738X  |4 aut 
700 1 |a Schaaf, Christian P.  |d 1978-  |e VerfasserIn  |0 (DE-588)130397318  |0 (DE-627)500686025  |0 (DE-576)298170345  |4 aut 
700 1 |a Fröhling, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)120890046  |0 (DE-627)080950302  |0 (DE-576)188733930  |4 aut 
700 1 |a Lichtner, Peter  |e VerfasserIn  |4 aut 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
700 1 |a Kazdal, Daniel  |d 1983-  |e VerfasserIn  |0 (DE-588)114929650X  |0 (DE-627)1009614088  |0 (DE-576)496635867  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Budczies, Jan  |d 1970-  |e VerfasserIn  |0 (DE-588)124086403  |0 (DE-627)706532724  |0 (DE-576)186167679  |4 aut 
773 0 8 |i Enthalten in  |t Translational oncology  |d Ann Arbor, Mich. : [Verlag nicht ermittelbar], 2008  |g 35(2023) vom: Sept., Artikel-ID 101706, Seite 1-10  |h Online-Ressource  |w (DE-627)57436482X  |w (DE-600)2443840-6  |w (DE-576)28492945X  |x 1936-5233  |7 nnas  |a Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD) 
773 1 8 |g volume:35  |g year:2023  |g month:09  |g elocationid:101706  |g pages:1-10  |g extent:10  |a Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD) 
856 4 0 |u https://doi.org/10.1016/j.tranon.2023.101706  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S193652332300092X  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230803 
993 |a Article 
994 |a 2023 
998 |g 124086403  |a Budczies, Jan  |m 124086403:Budczies, Jan  |d 910000  |d 912000  |e 910000PB124086403  |e 912000PB124086403  |k 0/910000/  |k 1/910000/912000/  |p 14  |y j 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 13 
998 |g 114929650X  |a Kazdal, Daniel  |m 114929650X:Kazdal, Daniel  |d 910000  |d 912000  |e 910000PK114929650X  |e 912000PK114929650X  |k 0/910000/  |k 1/910000/912000/  |p 12 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |e 910000PS1020440112  |e 912000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |p 11 
998 |g 120890046  |a Fröhling, Stefan  |m 120890046:Fröhling, Stefan  |d 50000  |e 50000PF120890046  |k 0/50000/  |p 9 
998 |g 130397318  |a Schaaf, Christian P.  |m 130397318:Schaaf, Christian P.  |d 910000  |d 911500  |e 910000PS130397318  |e 911500PS130397318  |k 0/910000/  |k 1/910000/911500/  |p 8 
998 |g 1057908746  |a Ball, Markus  |m 1057908746:Ball, Markus  |d 910000  |d 912000  |e 910000PB1057908746  |e 912000PB1057908746  |k 0/910000/  |k 1/910000/912000/  |p 7 
998 |g 1164102362  |a Beck, Susanne  |m 1164102362:Beck, Susanne  |d 910000  |d 912000  |e 910000PB1164102362  |e 912000PB1164102362  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 1033375632  |a Neumann, Olaf  |m 1033375632:Neumann, Olaf  |d 910000  |d 912000  |e 910000PN1033375632  |e 912000PN1033375632  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 122679940X  |a Kluck, Klaus  |m 122679940X:Kluck, Klaus  |d 910000  |d 912000  |e 910000PK122679940X  |e 912000PK122679940X  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 1106892291  |a Schwab, Constantin  |m 1106892291:Schwab, Constantin  |d 910000  |d 912000  |e 910000PS1106892291  |e 912000PS1106892291  |k 0/910000/  |k 1/910000/912000/  |p 3 
998 |g 1063753686  |a Endris, Volker  |m 1063753686:Endris, Volker  |d 50000  |e 50000PE1063753686  |k 0/50000/  |p 2 
998 |g 1247100944  |a Menzel, Michael  |m 1247100944:Menzel, Michael  |d 910000  |d 912000  |e 910000PM1247100944  |e 912000PM1247100944  |k 0/910000/  |k 1/910000/912000/  |p 1  |x j 
999 |a KXP-PPN1854258958  |e 4362698167 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Menzel","given":"Michael","role":"aut","display":"Menzel, Michael"},{"role":"aut","display":"Endris, Volker","family":"Endris","given":"Volker"},{"given":"Constantin","family":"Schwab","role":"aut","display":"Schwab, Constantin"},{"display":"Kluck, Klaus","role":"aut","family":"Kluck","given":"Klaus"},{"role":"aut","display":"Neumann, Olaf","family":"Neumann","given":"Olaf"},{"role":"aut","display":"Beck, Susanne","given":"Susanne","family":"Beck"},{"given":"Markus","family":"Ball","display":"Ball, Markus","role":"aut"},{"given":"Christian P.","family":"Schaaf","role":"aut","display":"Schaaf, Christian P."},{"given":"Stefan","family":"Fröhling","display":"Fröhling, Stefan","role":"aut"},{"display":"Lichtner, Peter","role":"aut","given":"Peter","family":"Lichtner"},{"display":"Schirmacher, Peter","role":"aut","given":"Peter","family":"Schirmacher"},{"role":"aut","display":"Kazdal, Daniel","given":"Daniel","family":"Kazdal"},{"role":"aut","display":"Stenzinger, Albrecht","family":"Stenzinger","given":"Albrecht"},{"given":"Jan","family":"Budczies","display":"Budczies, Jan","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"id":{"doi":["10.1016/j.tranon.2023.101706"],"eki":["1854258958"]},"note":["Online verfügbar: 14. Juni 2023","Gesehen am 03.08.2023"],"relHost":[{"origin":[{"publisherPlace":"Ann Arbor, Mich.","dateIssuedDisp":"2008-","publisher":"[Verlag nicht ermittelbar]","dateIssuedKey":"2008"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2008 -"],"title":[{"title_sort":"Translational oncology","title":"Translational oncology"}],"recId":"57436482X","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"text":"35(2023) vom: Sept., Artikel-ID 101706, Seite 1-10","year":"2023","pages":"1-10","volume":"35","extent":"10"},"note":["Gesehen am 23.06.2025"],"id":{"eki":["57436482X"],"issn":["1936-5233"],"zdb":["2443840-6"]},"disp":"Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Translational oncology"}],"name":{"displayForm":["Michael Menzel, Volker Endris, Constantin Schwab, Klaus Kluck, Olaf Neumann, Susanne Beck, Markus Ball, Christian Schaaf, Stefan Fröhling, Peter Lichtner, Peter Schirmacher, Daniel Kazdal, Albrecht Stenzinger, Jan Budczies"]},"origin":[{"dateIssuedDisp":"September 2023","dateIssuedKey":"2023"}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"title":[{"title":"Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)","title_sort":"Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)"}],"recId":"1854258958"} 
SRT |a MENZELMICHACCURATETU2023